Catholic Health Services, Mayo Clinic Team Up On COVID-19 Plasma Study

Greg Sleter
Monday, April 13, 2020

ROCKVILLE CENTRE, NY— Catholic Health Services (CHS) is joining a new research effort led by the Mayo Clinic that will use convalescent plasma donated by recovered COVID-19 patents to treat individuals who continue to fight the virus. Initial data available from studies using COVID-19 convalescent plasma to treat individuals with severe or life-threatening conditions related to the virus indicate that a single dose (200 milliliters/6.8 ounces) of plasma showed a benefit for some patients, leading to improvement. People who recover from COVID-19 do so, in part, because their blood contains antibodies that are able to fight the virus. Prior research of other viruses found that treating patients with plasma obtained from those who have recovered from the same virus leads to rapid improvement. “Catholic Health Services is excited to work with the Mayo Clinic as part of the effort to develop new treatments for COVID-19,” said CHS Senior Vice President and Chief Quality Officer Jason Golbin, DO, MBA, MS. “We will be contacting patients treated by CHS for COVID-19 to request their participation in this study, but all who have recovered are welcome.” Potential donors must have a prior, verified diagnosis of COVID-19, but are now symptom-free and fully recovered. In addition to being in good health, donors must also be at least 18 years of age and weigh at least 110 pounds. The plasma can be administered only to a consenting COVID-19 patient or a patient whose family member offers consent. The treatment will be given to those patients judged by a physician to be at high risk of disease progression to severe or life-threatening. Additional information and details on how to donate may be obtained by calling CHS at 1 (855) CHS-4500.